Skip to main content

Table 3 Therapy after admission of the lowest and highest HbA1c groups

From: Prognostic value of HbA1c for in-hospital and short-term mortality in patients with acute coronary syndrome: a systematic review and meta-analysis

 Therapy after admissionLowest (%)Highest (%)Total number
LowestHighest
Thrombosis (%), studies = 37.4011.8636,3286808
PCI (%), studies = 1394.8688.9242,9859124
PCI (successful) (%), studies = 692.9990.0554773114
CABG (%), studies = 319.9016.4439,2916326
Antiplatelet agent (%), studies = 478.4484.254058584
Aspirin (%), studies = 398.4697.8836,5656925
Clopidogrel or Tigrilo (%), studies = 372.3269.1636,5656925
Lipid lowering drugs (%), studies = 792.7489.9340,6237509
Beta blockers (%), studies = 794.7990.9840,6237509
ACEI/ARB (%), studies = 773.9277.3440,6237509
  1. PCI percutaneous coronary intervention, CABG coronary artery bypass grafting, ACEI angiotensin-converting enzyme inhibitors, ARB angiotensin receptor blocker